Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc (NY: OGEN )

1.040 +0.050 (+5.05%)
Official Closing Price Updated: 8:00 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 57,465
Open 1.010
Bid (Size) 1.010 (18)
Ask (Size) 1.060 (1)
Prev. Close 0.9900
Today's Range 1.000 - 1.055
52wk Range 0.9700 - 7.740
Shares Outstanding 4,480,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OGEN Stock Earnings: Oragenics Reported Results for Q4 2023
Oragenics just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Why Oragenics (OGEN) Shares Are Falling
Oragenics shares are trading lower by 21% during Tuesday's session. The company announced pricing of its public offering. 
Via Benzinga

Performance

YTD
-84.66%
-84.66%
1 Month
-48.51%
-48.51%
3 Month
-27.27%
-27.27%
6 Month
-84.66%
-84.66%
1 Year
-68.48%
-68.48%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results
Via Benzinga
OGEN Stock Earnings: Oragenics Reported Results for Q1 2024
Via InvestorPlace
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
From Oragenics, Inc.
Via Business Wire
Oragenics, Inc. Files 10K and Provides Company Update
From Oragenics, Inc.
Via Business Wire
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
From Oragenics, Inc.
Via Business Wire
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
From Oragenics, Inc.
Via Business Wire
Oragenics Announces Closing of Public Offering
From Oragenics, Inc.
Via Business Wire
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
Via Benzinga
Topics Stocks
Exposures US Equities
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Dips 200 Points; TJX Posts Upbeat Sales
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
Via InvestorPlace
Why Is Integral Ad Science (IAS) Stock Down 29% Today?
Via InvestorPlace
Why Is Oragenics (OGEN) Stock Down 45% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.